Literature DB >> 11348668

Enhanced systemic and mucosal antibody responses to a model protein antigen after intranasal and intratracheal immunisation using Bacillus firmus as an adjuvant.

P Mlcková1, D Cechová, P Chalupná, O Novotná, L Prokesová.   

Abstract

Bacillus firmus, a non-pathogenic Gram positive (G+) bacterium of the external environment was investigated for immunomodulatory properties. It stimulated an increase in anti-ovalbumin IgG in sera, bronchoalveolar lavages and intestinal washings after both intranasal (i.n.) and intratracheal (i.t.) immunisation, and enhanced anti-ovalbumin IgA in intestinal secretions and in bronchoalveolar lavage fluid after i.n. or i.t. immunisation, respectively. The immunomodulatory effect of B. firmus on antibody formation was antigen specific.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11348668     DOI: 10.1016/s0165-2478(01)00192-4

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  9 in total

1.  Mucosal and systemic adjuvant activity of alphavirus replicon particles.

Authors:  Joseph M Thompson; Alan C Whitmore; Jennifer L Konopka; Martha L Collier; Erin M B Richmond; Nancy L Davis; Herman F Staats; Robert E Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

2.  Intratracheal and intranasal immunization with ovalbumin conjugated with Bacillus firmus as a carrier in mice.

Authors:  P Mlcková; M Polácek; D Cechová; L Marusková; I Stanková; P Chalupná; O Novotná; J Julák; L Prokesová
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.099

3.  Stimulation of protective and cross-protective immunity against influenza B virus after adjuvant mucosal immunization of mice.

Authors:  L Prokesová; P Zanvit; M Havlícková; J Tácner; M Jirkovská; P Petrásková; O Novotná; D Cechová; J Julák
Journal:  Folia Microbiol (Praha)       Date:  2010-02-07       Impact factor: 2.099

4.  Whole metagenome profiling reveals skin microbiome-dependent susceptibility to atopic dermatitis flare.

Authors:  Kern Rei Chng; Angeline Su Ling Tay; Chenhao Li; Amanda Hui Qi Ng; Jingjing Wang; Bani Kaur Suri; Sri Anusha Matta; Naomi McGovern; Baptiste Janela; Xuan Fei Colin C Wong; Yang Yie Sio; Bijin Veonice Au; Andreas Wilm; Paola Florez De Sessions; Thiam Chye Lim; Mark Boon Yang Tang; Florent Ginhoux; John E Connolly; E Birgitte Lane; Fook Tim Chew; John E A Common; Niranjan Nagarajan
Journal:  Nat Microbiol       Date:  2016-07-11       Impact factor: 17.745

5.  Immunomodulatory properties of subcellular fractions of a G+ bacterium, Bacillus firmus.

Authors:  Dana Cechova; Michaela Novakova; Karel Mikulik; Olga Novotna; Jaroslav Julak; Peter Zanvit; Ludmila Prokesova
Journal:  Folia Microbiol (Praha)       Date:  2012-08-09       Impact factor: 2.099

6.  Role of T cells in the adjuvant effect of Bacillus firmus on the immune system of mice: intranasal and intratracheal immunization study with ovalbumin.

Authors:  P Mlcková; D Cechová; L Marusková; P Chalupná; O Novotná; L Prokesová
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

7.  The PorB porin from commensal Neisseria lactamica induces Th1 and Th2 immune responses to ovalbumin in mice and is a potential immune adjuvant.

Authors:  Xiuping Liu; Lee M Wetzler; Paola Massari
Journal:  Vaccine       Date:  2007-12-26       Impact factor: 3.641

8.  Immunomodulatory effects of Bacillus firmus on mouse peritoneal cells in vitro.

Authors:  I Lomáková; P Petrásková; I Sterzl; L Prokesová
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.629

9.  Adjuvant effect of Bacillus firmus in intranasal immunization of guinea pigs with inactivated type B infuenza virus.

Authors:  M Havlícková; L Prokesová; P Zanvit; J Tácner; R Limberková
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.